Chesapeake Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $405K | Hold |
2,905
| – | – | 0.12% | 118 |
|
|
2025
Q4 | $357K | Buy |
2,905
+517
| +22% | +$62.8K | 0.11% | 122 |
|
|
2025
Q3 | $265K | Buy |
2,388
+50
| +2% | +$5.68K | 0.08% | 144 |
|
|
2025
Q2 | $259K | Hold |
2,338
| – | – | 0.09% | 143 |
|
|
2025
Q1 | $262K | Sell |
2,338
-2,328
| -50% | -$240K | 0.09% | 142 |
|
|
2024
Q4 | $431K | Hold |
4,666
| – | – | 0.15% | 116 |
|
|
2024
Q3 | $391K | Hold |
4,666
| – | – | 0.13% | 119 |
|
|
2024
Q2 | $320K | Sell |
4,666
-38
| -0.8% | -$2.54K | 0.12% | 126 |
|
|
2024
Q1 | $345K | Buy |
4,704
+38
| +0.8% | +$2.92K | 0.13% | 122 |
|
|
2023
Q4 | $378K | Hold |
4,666
| – | – | 0.15% | 116 |
|
|
2023
Q3 | $350K | Sell |
4,666
-90
| -2% | -$6.92K | 0.15% | 116 |
|
|
2023
Q2 | $367K | Hold |
4,756
| – | – | 0.14% | 114 |
|
|
2023
Q1 | $395K | Sell |
4,756
-41
| -0.9% | -$3.4K | 0.16% | 111 |
|
|
2022
Q4 | $412K | Hold |
4,797
| – | – | 0.18% | 110 |
|
|
2022
Q3 | $296K | Hold |
4,797
| – | – | 0.14% | 136 |
|
|
2022
Q2 | $297K | Hold |
4,797
| – | – | 0.13% | 135 |
|
|
2022
Q1 | $285K | Sell |
4,797
-122
| -2% | -$7.8K | 0.1% | 156 |
|
|
2021
Q4 | $357K | Buy |
4,919
+253
| +5% | +$17.4K | 0.12% | 149 |
|
|
2021
Q3 | $326K | Hold |
4,666
| – | – | 0.12% | 155 |
|
|
2021
Q2 | $321K | Hold |
4,666
| – | – | 0.1% | 174 |
|
|
2021
Q1 | $302K | Sell |
4,666
-336
| -7% | -$21.7K | 0.1% | 182 |
|
|
2020
Q4 | $291K | Hold |
5,002
| – | – | 0.1% | 182 |
|
|
2020
Q3 | $316K | Hold |
5,002
| – | – | 0.12% | 161 |
|
|
2020
Q2 | $385K | Hold |
5,002
| – | – | 0.15% | 137 |
|
|
2020
Q1 | $374K | Sell |
5,002
-100
| -2% | -$6.91K | 0.17% | 122 |
|
|
2019
Q4 | $332K | Sell |
5,102
-350
| -6% | -$22.8K | 0.13% | 151 |
|
|
2019
Q3 | $346K | Sell |
5,452
-114
| -2% | -$7.45K | 0.14% | 143 |
|
|
2019
Q2 | $376K | Sell |
5,566
-820
| -13% | -$53.9K | 0.16% | 140 |
|
|
2019
Q1 | $415K | Sell |
6,386
-150
| -2% | -$9.97K | 0.18% | 126 |
|
|
2018
Q4 | $409K | Sell |
6,536
-375
| -5% | -$26.2K | 0.2% | 117 |
|
|
2018
Q3 | $534K | Hold |
6,911
| – | – | 0.24% | 104 |
|
|
2018
Q2 | $490K | Sell |
6,911
-160
| -2% | -$11.3K | 0.23% | 106 |
|
|
2018
Q1 | $534K | Buy |
+7,071
| New | +$562K | 0.25% | 95 |
|
Other funds holding GILD
VCM
VPM
Chesapeake Wealth Management's GILD Position: Q1 2026 in Review
Chesapeake Wealth Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 2,905 shares worth $405K. The position accounts for 0.12% of the portfolio, ranked #118.
Chesapeake Wealth Management first reported a position in GILD in Q1 2018 and has held it in 33 quarters since. The position peaked at $534K in Q3 2018. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Chesapeake Wealth Management held 2,905 shares of Gilead Sciences worth $405K as of Q1 2026.
- Chesapeake Wealth Management left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up 0.12% of Chesapeake Wealth Management's portfolio in Q1 2026, its #118 holding.
- Chesapeake Wealth Management first reported a position in Gilead Sciences in Q1 2018 and has held it in 33 quarters since.
- Chesapeake Wealth Management's Gilead Sciences position peaked at $534K in Q3 2018.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Chesapeake Wealth Management's 13F filing for Q1 2026, filed 18 May 2026.